Torrens Michael, Chung Caroline, Chung Hyun-Tai, Hanssens Patrick, Jaffray David, Kemeny Andras, Larson David, Levivier Marc, Lindquist Christer, Lippitz Bodo, Novotny Josef, Paddick Ian, Prasad Dheerendra, Yu Chung Ping
Department of Neurosurgery, Hygeia Hospital, Athens, Greece.
J Neurosurg. 2014 Dec;121 Suppl:2-15. doi: 10.3171/2014.7.GKS141199.
This report has been prepared to ensure more uniform reporting of Gamma Knife radiosurgery treatment parameters by identifying areas of controversy, confusion, or imprecision in terminology and recommending standards.
Several working group discussions supplemented by clarification via email allowed the elaboration of a series of provisional recommendations. These were also discussed in open session at the 16th International Leksell Gamma Knife Society Meeting in Sydney, Australia, in March 2012 and approved subject to certain revisions and the performance of an Internet vote for approval from the whole Society. This ballot was undertaken in September 2012.
The recommendations in relation to volumes are that Gross Target Volume (GTV) should replace Target Volume (TV); Prescription Isodose Volume (PIV) should generally be used; the term Treated Target Volume (TTV) should replace TVPIV, GTV in PIV, and so forth; and the Volume of Accepted Tolerance Dose (VATD) should be used in place of irradiated volume. For dose prescription and measurement, the prescription dose should be supplemented by the Absorbed Dose, or DV% (for example, D95%), the maximum and minimum dose should be related to a specific tissue volume (for example, D2% or preferably D1 mm3), and the median dose (D50%) should be recorded routinely. The Integral Dose becomes the Total Absorbed Energy (TAE). In the assessment of planning quality, the use of the Target Coverage Ratio (TTV/ GTV), Paddick Conformity Index (PCI = TTV2/[GTV · PIV]), New Conformity Index (NCI = [GTV · PIV]/TTV2), Selectivity Index (TTV/PIV), Homogeneity Index (HI = [D2% –D98%]/D50%), and Gradient Index (GI = PIV0.5/PIV) are reemphasized. In relation to the dose to Organs at Risk (OARs), the emphasis is on dose volume recording of the VATD or the dose/volume limit (for example, V10) in most cases, with the additional use of a Maximum Dose to a small volume (such as 1 mm3) and/or a Point Dose and Mean Point Dose in certain circumstances, particularly when referring to serial organs. The recommendations were accepted by the International Leksell Gamma Knife Society by a vote of 92% to 8%.
An agreed-upon and uniform terminology and subsequent standardization of certain methods and procedures will advance the clinical science of stereotactic radiosurgery.
编写本报告是为了通过识别术语方面存在争议、混淆或不精确的领域并推荐标准,确保伽玛刀放射外科治疗参数的报告更加统一。
通过几次工作组讨论,并辅以电子邮件澄清,从而制定了一系列临时建议。这些建议在2012年3月于澳大利亚悉尼举行的第16届国际Leksell伽玛刀协会会议的公开会议上也进行了讨论,并在进行某些修订以及开展全协会网络投票表决以获得批准后获得通过。此次投票于2012年9月进行。
关于体积的建议是,大体靶体积(GTV)应取代靶体积(TV);一般应使用处方等剂量体积(PIV);治疗靶体积(TTV)一词应取代TVPIV、PIV中的GTV等;应使用耐受剂量体积(VATD)取代照射体积。对于剂量处方和测量,处方剂量应补充吸收剂量或DV%(例如,D95%),最大和最小剂量应与特定组织体积相关(例如,D2%或更优为D1 mm³),并且应常规记录中位剂量(D50%)。积分剂量变为总吸收能量(TAE)。在计划质量评估中,再次强调使用靶区覆盖比(TTV/GTV)、帕迪克适形指数(PCI = TTV²/[GTV·PIV])、新适形指数(NCI = [GTV·PIV]/TTV²)、选择性指数(TTV/PIV)、均匀性指数(HI = [D2% – D98%]/D50%)和梯度指数(GI = PIV0.5/PIV)。关于危及器官(OARs)的剂量,在大多数情况下重点是记录VATD的剂量体积或剂量/体积限值(例如,V10),在某些情况下,特别是涉及串联器官时,还需额外使用小体积(如1 mm³)的最大剂量和/或点剂量及平均点剂量。这些建议以92%对8%的投票结果被国际Leksell伽玛刀协会接受。
商定并统一的术语以及随后对某些方法和程序的标准化将推动立体定向放射外科的临床科学发展。